Annual Drug Patent Expirations for VAGIFEM
Vagifem is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for VAGIFEM.
This drug has thirteen patent family members in ten countries.
The generic ingredient in VAGIFEM is estradiol. One supplier is listed for this compound. Additional details are available on the estradiol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
